The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.
about
S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-kappa BLigand-Independent EGFR SignalingThe role of NF-κB in the pathogenesis of gliomaIKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibitionSensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescenceRIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysisSema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation.Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy.Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantOxidized LDL induces FAK-dependent RSK signaling to drive NF-κB activation and VCAM-1 expressionCytoplasmic TRADD confers a worse prognosis in glioblastomaRIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen speciesOpposing effect of EGFRWT on EGFRvIII-mediated NF-κB activation with RIP1 as a cell death switch.Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.The NFκB pathway: a therapeutic target in glioblastoma.Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer.RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection.Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.Relevance of necroptosis in cancer.The receptor interacting protein 1 mediates a link between NFkappaB and PI3-kinase signaling.RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging.Delayed cell death associated with mitotic catastrophe in γ-irradiated stem-like glioma cells.NF-κB Signalling in Glioblastoma.Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors.RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway.
P2860
Q23921468-8D6F90C7-B7EF-4ACB-A22E-6D375804EECCQ26797495-4BC40204-4C10-45E8-9BC2-72A386B18332Q26825502-01B533D3-D610-497B-96EE-9DB25C8C2E86Q33276239-5FF790E2-4318-44BC-B7E8-97D75DFD56A8Q33576820-2266D61C-071D-4D90-B4CC-5B14611FB17DQ33933870-121704EF-39F7-497E-803F-CF72AB05C7A6Q34393757-A51027CF-D830-4743-9D4D-F344B8F5B65BQ34714664-4753793A-5911-459E-A5DC-1B66240C5AA5Q35783079-FB1FC6B9-84CE-40C5-8052-4D08356C1D60Q35783593-89A4A35F-3CC1-4D4A-979E-A0880E1E0EFAQ36111622-9063E3D5-0B6C-4D8B-980F-FD8FB94E2139Q36347249-4FDEDA2F-8AC5-4B88-B093-0932B178772EQ36750717-3FFFB34D-D333-4C42-BFA5-6321F6061FFCQ36856954-D113A8BD-2187-4058-8CF9-681A955EBD3DQ37061012-C5266BA7-526F-4B4E-A937-E51D6B546A47Q37151621-B306F359-BB58-47C8-85CE-CCD0D80A0CAEQ37192269-CA3AC1E9-0DBD-44FE-9D9F-2B20B6D9B57CQ37279893-0E5535D6-2999-4B55-B2FE-942AA851E31CQ37928304-C8ADC110-DA4B-4481-9A57-D0E0D47B8610Q37995693-B2D6A3CE-0A39-401D-A300-ED42088F724BQ38484194-5E63FA7D-C401-4B84-945D-52432CFD6BDFQ38624686-0C341881-B3DC-4BC5-A66F-EB52E5CAAF70Q38876475-6E56CC47-5E9A-4584-A09F-579FF81680B7Q39030578-1127A6C9-5B74-477B-B0E1-50B8F6F3092DQ39856683-18AF89B4-79B8-47A5-90D7-605F8DA8236CQ42164592-2821121E-A492-42FC-A76D-710CF2F9B25DQ42363680-DBF930AC-081A-45EA-AAE8-1F2CC82B5941Q42788716-F8E26929-292E-4640-9675-F62D12148333Q52091959-8B0CA46B-CB1F-492E-8936-33ADE1164810Q53214900-01267EC3-527D-4139-B9E7-424EB7BF4F19Q55255265-BFD17B2B-1DD2-47EB-901F-1EF547D54AAA
P2860
The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The receptor interacting prote ...... rse prognosis in glioblastoma.
@en
The receptor interacting prote ...... rse prognosis in glioblastoma.
@nl
type
label
The receptor interacting prote ...... rse prognosis in glioblastoma.
@en
The receptor interacting prote ...... rse prognosis in glioblastoma.
@nl
prefLabel
The receptor interacting prote ...... rse prognosis in glioblastoma.
@en
The receptor interacting prote ...... rse prognosis in glioblastoma.
@nl
P2093
P2860
P1433
P1476
The receptor interacting prote ...... rse prognosis in glioblastoma.
@en
P2093
Amyn A Habib
Bruce E Mickey
Christopher J Madden
David A Boothman
Dawen Zhao
Debabrata Saha
Deepti B Ramnarain
Guanghua Xiao
Jack M Raisanen
Kimmo J Hatanpaa
P2860
P304
P356
10.1158/0008-5472.CAN-08-4079
P407
P577
2009-04-01T00:00:00Z